{"content":"<li class=\"n-box-item date-title\" data-end=\"1385441999\" data-start=\"1385355600\" data-txt=\"Friday, December 20, 2019\">Monday, November 25, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1432341\" data-ts=\"1385423201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCSL\" target=\"_blank\">OCSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432341-fifth-street-finance-misses-by-0_03\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fifth Street Finance misses by $0.03</a></h4><ul>\n<li>Fifth Street Finance (FSC): FQ4 NII of $0.23 <font color=\"red\">misses by $0.03</font>.</li>\n<li>Shares  <font color=\"red\">-2.2%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432341\" data-linked=\"Fifth Street Finance misses by $0.03\" data-tweet=\"$OCSL - Fifth Street Finance misses by $0.03 https://seekingalpha.com/news/1432341-fifth-street-finance-misses-by-0_03?source=tweet\" data-url=\"https://seekingalpha.com/news/1432341-fifth-street-finance-misses-by-0_03\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432321\" data-ts=\"1385422754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PWRD\" target=\"_blank\">PWRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432321-perfect-world-issues-solid-guidance-new-games-performing-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perfect World issues solid guidance, new games performing well</a></h4><ul>\n<li>Perfect World (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PWRD\" title=\"Perfect World Co., Ltd.\">PWRD</a>) expects Q4 revenue of RMB850M-892M ($139.6M-$146.5M), above a consensus of $137.3M.</li>\n<li>The company attributes its Q3 beat to the strong performance of new titles, including <em>Swordsman Online</em> and <em>Saint Seiya Online</em>. Average concurrent users for Chinese games rose to 778K from 742K in Q2 and 601K in the year-ago period.</li>\n<li>Going forward, Perfect World is counting on the launch of <em>DOTA2</em>, as well as a Chinese version of U.S./European title <em>Neverwinter</em>, to maintain its momentum.</li>\n<li>Sales/marketing spend rose 10% Q/Q and 21% Y/Y to $34.9M. The Y/Y rate is well below the 102% clip Perfect World <a href=\"https://seekingalpha.com/currents/post/1231282\" target=\"_blank\">reported for Q2</a>, much to the <a href=\"https://seekingalpha.com/currents/post/1233332\" target=\"_blank\">concern</a> of investors. R&amp;D spend rose 19% Q/Q and 20% Y/Y to $38.8M.  Gross margin was76.7%, up from 75.5% in Q2 but down from 81.5% a year ago.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/PWRD\" title=\"Perfect World Co., Ltd.\">PWRD</a> <font color=\"green\">+8.4%</font> AH. <a href=\"https://seekingalpha.com/currents/post/1432161\" target=\"_blank\">Q3 results</a>, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432321\" data-linked=\"Perfect World issues solid guidance, new games performing well\" data-tweet=\"$PWRD - Perfect World issues solid guidance, new games performing well https://seekingalpha.com/news/1432321-perfect-world-issues-solid-guidance-new-games-performing-well?source=tweet\" data-url=\"https://seekingalpha.com/news/1432321-perfect-world-issues-solid-guidance-new-games-performing-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432261\" data-ts=\"1385419355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432261-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><b>Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/PWRD' title='Perfect World Co., Ltd.'>PWRD</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+4%</font>.</li><li><b>Top Losers</b><b><b>, as of 5:15 p.m.</b>:</b> <a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ATAX' title='America First Multifamily Investors, L.P'>ATAX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='red'>-3%</font>. &nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"1432261\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$PWRD $IMUC $WDAY - After Hours Gainers / Losers https://seekingalpha.com/news/1432261-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1432261-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432241\" data-ts=\"1385418422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432241-palo-altos-guidance-in-line-investors-applaud-deferred-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto&#39;s guidance in-line; investors applaud deferred revenue growth</a></h4><ul>\n<li>Palo Alto Networks (NYSE:<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a>) <a href=\"https://twitter.com/TechStockRadar/status/405091690739814400\" target=\"_blank\">has guided</a> on its FQ1 CC for FQ2 revenue of $132M-$136M and EPS of $0.08-$0.09, in-line with a consensus of $132.3M and $0.09.</li>\n<li>Investors, however, are more interested in the fact Palo Alto's deferred revenue balance rose 12% Q/Q and 74% Y/Y in FQ1 to $279M. The Y/Y growth rate was well above FQ1's 49% revenue growth rate.</li>\n<li>The deferred revenue growth highlights Palo Alto's strong focus (relative to some peers) on security services subscriptions, which only get recognized a quarter at a time (even if an entire subscription is paid up-front). Services revenue rose 73% Y/Y, and made up 41% of total revenue. Product revenue rose 36%.</li>\n<li>Opex rose 56% Y/Y, thanks in large part to a 58% increase in sales/marketing spend to $67.4M (53% of revenue).</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a> <font color=\"green\">+8%</font> AH. <a href=\"https://seekingalpha.com/currents/post/1431951\" target=\"_blank\">FQ1 results</a>, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432241\" data-linked=\"Palo Alto&#39;s guidance in-line; investors applaud deferred revenue growth\" data-tweet=\"$PANW - Palo Alto&#39;s guidance in-line; investors applaud deferred revenue growth https://seekingalpha.com/news/1432241-palo-altos-guidance-in-line-investors-applaud-deferred-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/1432241-palo-altos-guidance-in-line-investors-applaud-deferred-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432191\" data-ts=\"1385416901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432191-insider-buy-at-j-c-penney\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buy at J.C. Penney</a></h4><ul> <li>J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) CEO Mike Ullman snapped up 112K shares of the company in an insider buy last Friday.</li> <li>The exec scored the shares at $8.95 a pop.</li> <li><a href=\"http://www.sec.gov/Archives/edgar/data/1166126/000114036113044074/xslF345X03/doc1.xml\" target=\"_blank\">SEC Form 4</a></li> <li>JCP <font color='green'>+2.8%</font> AH to $9.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1432191\" data-linked=\"Insider buy at J.C. Penney\" data-tweet=\"$JCP - Insider buy at J.C. Penney https://seekingalpha.com/news/1432191-insider-buy-at-j-c-penney?source=tweet\" data-url=\"https://seekingalpha.com/news/1432191-insider-buy-at-j-c-penney\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432171\" data-ts=\"1385416856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432171-nuance-issues-soft-guidance-bookings-relatively-healthy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance issues soft guidance, bookings relatively healthy</a></h4><ul>\n<li>For the second straight quarter (<a href=\"https://seekingalpha.com/currents/post/1199182\" target=\"_blank\">previous</a>), Nuance (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NUAN\" title=\"Nuance Communications, Inc.\">NUAN</a>) has beat quarterly estimates and provided below-consensus guidance. In <a href=\"https://docs.google.com/viewer?url=http%3A%2F%2Fwww.nuance.com%2Fcompany%2Finvestor-relations%2F2013-11-25-Nuance-Q413-Call-Remarks.pdf\" target=\"_blank\">prepared remarks</a>, the voice recognition software leader guides for FQ1 revenue of $477M-$487M and EPS of $0.18-$0.21, below a consensus of $494.7M and $0.33. Also, Nuance is guiding for FY14 (ends Sep. '14) revenue of $2.03B-$2.09B and EPS of $1.05-$1.15, largely below a consensus of $2.08B and $1.41.</li>\n<li>One bright spot: Nuance forecasts FY14 bookings of $2.15B-$2.25B, up from an FY13 level of $1.92B and implying a book-to-bill above 1 (FY13 book-to-bill was 0.98).</li>\n<li>Nuance once more says the transition to cloud/subscription-based sales from up-front licenses is hurting near-term revenue. The company also states ongoing weakness in healthcare transcription sales (<a href=\"https://seekingalpha.com/currents/post/814551\" target=\"_blank\">previous</a>), smartphone consolidation (gives Apple/Samsung more control), and the adoption of services-based mobile models (such as Siri) will hurt FY14 sales. Meanwhile, major mobile, cloud, and healthcare R&amp;D investments will pressure EPS.</li>\n<li>On the other hand, Nuance expects growth in the enterprise, automotive, diagnostics, and managed print services markets, as well as for its DragonTV, Clintegrity (clinical documentation), and voicemail-to-text offerings.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/NUAN\" title=\"Nuance Communications, Inc.\">NUAN</a> <font color=\"red\">-4.9%</font> AH. <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&amp;c=110330&amp;eventID=5045157\" target=\"_blank\">CC</a> at 5PM ET. FQ4 results, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432171\" data-linked=\"Nuance issues soft guidance, bookings relatively healthy\" data-tweet=\"$NUAN - Nuance issues soft guidance, bookings relatively healthy https://seekingalpha.com/news/1432171-nuance-issues-soft-guidance-bookings-relatively-healthy?source=tweet\" data-url=\"https://seekingalpha.com/news/1432171-nuance-issues-soft-guidance-bookings-relatively-healthy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432141\" data-ts=\"1385415968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADT\" target=\"_blank\">ADT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432141-meister-to-move-on-from-adt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meister to move on from ADT</a></h4><ul>\n<li>ADT Corp. (<a href=\"https://seekingalpha.com/symbol/ADT\" title=\"The ADT Corporation\">ADT</a> <font color=\"red\">-5.8%</font>) fell and couldn't get up today after Corvex Management <a href=\"http://online.wsj.com/news/articles/SB10001424052702304281004579220173214647530?mod=pls_whats_news_us_business_f\" target=\"_blank\">set the cashing in</a> of its year-old investment in the company. Corvex founder Keith Meister resigned from the ADT board, effective immediately.</li>\n<li>Corvex is ADT's 3rd largest shareholder with 11.1M shares, or 5.3% of the company. ADT will buyback 10.24M of those shares at Friday's closing price of $44.01 (the stock closed today at $41.46). Corvex will get a return of about 20% on its investment.</li>\n<li>Shortly after last year's IPO of ADT, Corvex said the shares were worth at least $61 each and called for a buyback of 30% of the stock. The board has largely complied with Meister's strategy, including the taking out of debt to finance the buybacks. Once a current<a href=\"http://www.sec.gov/Archives/edgar/data/1546640/000119312513452574/d633029d8k.htm\" target=\"_blank\"> $400M purchase</a> in the works is complete, the company will have spent about $2.4B to retire about 20% of the float.</li>\n<li><a href=\"http://www.sec.gov/Archives/edgar/data/1546640/000119312513452297/d634201d8k.htm\" target=\"_blank\">SEC Form 8-K</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432141\" data-linked=\"Meister to move on from ADT\" data-tweet=\"$ADT - Meister to move on from ADT https://seekingalpha.com/news/1432141-meister-to-move-on-from-adt?source=tweet\" data-url=\"https://seekingalpha.com/news/1432141-meister-to-move-on-from-adt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432071\" data-ts=\"1385415028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432071-universal-display-strikes-oled-lighting-deal-with-philips-shares-plus-2_1-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display strikes OLED lighting deal with Philips, shares +2.1% AH</a></h4><ul>\n<li>Universal Display (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OLED\" title=\"Universal Display Corporation\">OLED</a>) will supply Philips with phosphorescent OLED materials for use in solid-state lighting applications. (PR)</li>\n<li>Universal <a href=\"https://seekingalpha.com/currents/post/109246\" target=\"_blank\">has already struck</a> OLED lighting deals with several Asian OEMs. Though still at a very early stage in its development, OLED lighting is <a href=\"https://seekingalpha.com/currents/post/220251\" target=\"_blank\">expected to emerge</a> as a rival to LED lighting in time. The technology's proponents argue it offers thickness, energy efficiency, and temperature benefits over alternatives.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432071\" data-linked=\"Universal Display strikes OLED lighting deal with Philips, shares +2.1% AH\" data-tweet=\"$OLED - Universal Display strikes OLED lighting deal with Philips, shares +2.1% AH https://seekingalpha.com/news/1432071-universal-display-strikes-oled-lighting-deal-with-philips-shares-plus-2_1-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1432071-universal-display-strikes-oled-lighting-deal-with-philips-shares-plus-2_1-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432061\" data-ts=\"1385414987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTS\" target=\"_blank\">TTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432061-sac-capital-discloses-5-percent-stake-in-tile-shop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAC Capital discloses 5% stake in Tile Shop</a></h4><ul><li>Steven Cohen's shop discloses a 2.57M share or 5% stake in embattled Tile Shop Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TTS' title='Tile Shop Holdings, Inc.'>TTS</a>).</li><li>Shares&nbsp;<font color='green'>+1.1%</font>&nbsp;AH</li><li><a href=\"http://www.sec.gov/Archives/edgar/data/1451928/000089914013000567/s10784012a.htm\" target=\"_blank\">SEC Form 13-G</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1432061\" data-linked=\"SAC Capital discloses 5% stake in Tile Shop\" data-tweet=\"$TTS $TTSH - SAC Capital discloses 5% stake in Tile Shop https://seekingalpha.com/news/1432061-sac-capital-discloses-5-percent-stake-in-tile-shop?source=tweet\" data-url=\"https://seekingalpha.com/news/1432061-sac-capital-discloses-5-percent-stake-in-tile-shop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432031\" data-ts=\"1385414762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432031-nuance-communications-beats-by-0_01\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance Communications beats by $0.01</a></h4><ul>     <li>Nuance Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NUAN\" title=\"Nuance Communications, Inc.\">NUAN</a>): FQ4 EPS of $0.30 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Non-GAAP revenue of $490.4M <font color=\"green\">beats by $0.84M</font>. GAAP revenue of $472.24M. Shares  <font color=\"red\">-3.1% </font>AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1432031\" data-linked=\"Nuance Communications beats by $0.01\" data-tweet=\"$NUAN - Nuance Communications beats by $0.01 https://seekingalpha.com/news/1432031-nuance-communications-beats-by-0_01?source=tweet\" data-url=\"https://seekingalpha.com/news/1432031-nuance-communications-beats-by-0_01\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1432021\" data-ts=\"1385414619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1432021-workdays-fq4-guidance-strong-unearned-revenue-growth-accelerates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday&#39;s FQ4 guidance strong, unearned revenue growth accelerates</a></h4><ul>\n<li>Workday (NYSE:<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a>) is guiding for FQ4 revenue of $133M-$138M, soundly above a $128.9M consensus.</li>\n<li>The cloud HR/ERP software vendor's unearned revenue balance rose 8% Q/Q and 40% Y/Y to $351.8M; Y/Y growth accelerated from FQ2's 32% clip.</li>\n<li>Subscription revenue (74% of total revenue) rose 82% Y/Y, and services revenue rose 61%.</li>\n<li>Operating cash flow was $7.1M, and free cash flow was -$9.7M (less than a net loss of $21.3M).</li>\n<li>Much like <a href=\"https://seekingalpha.com/currents/post/1419212\" target=\"_blank\">Salesforce</a>, Workday continues to spend aggressively: R&amp;D and sales/marketing spend both rose 56% Y/Y to $41.9M and $49.4M, respectively.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a> <font color=\"green\">+6.3%</font> AH. <a href=\"https://edge.media-server.com/m/p/wsw27myo/lan/en\" target=\"_blank\">CC</a> at 5PM ET.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1431941\" target=\"_blank\">FQ3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1432021\" data-linked=\"Workday&#39;s FQ4 guidance strong, unearned revenue growth accelerates\" data-tweet=\"$WDAY - Workday&#39;s FQ4 guidance strong, unearned revenue growth accelerates https://seekingalpha.com/news/1432021-workdays-fq4-guidance-strong-unearned-revenue-growth-accelerates?source=tweet\" data-url=\"https://seekingalpha.com/news/1432021-workdays-fq4-guidance-strong-unearned-revenue-growth-accelerates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431951\" data-ts=\"1385413707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431951-palo-alto-networks-beats-by-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks  beats by $0.01, beats on revenue</a></h4><ul>     <li>Palo Alto Networks (NYSE:<a href=\"https://seekingalpha.com/symbol/PANW\" title=\"Palo Alto Networks\">PANW</a>): FQ1 EPS of $0.08 <font color=\"green\">beats by $0.01</font>.</li>\n<li>Revenue of $128.2M (+49% Y/Y) <font color=\"green\">beats by $7.39M</font>. Shares  <font color=\"green\">+7.42%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1431951\" data-linked=\"Palo Alto Networks  beats by $0.01, beats on revenue\" data-tweet=\"$PANW - Palo Alto Networks beats by $0.01, beats on revenue https://seekingalpha.com/news/1431951-palo-alto-networks-beats-by-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1431951-palo-alto-networks-beats-by-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431941\" data-ts=\"1385413520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431941-workday-beats-by-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday beats by $0.05, beats on revenue</a></h4><ul>     <li>Workday (NYSE:<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a>): FQ3 EPS of -$0.12 <font color=\"green\">beats by $0.05</font>.</li>\n<li>Revenue of $127.9M (+76% Y/Y) <font color=\"green\">beats by $10.22M</font>. Shares  <font color=\"green\">+7.12%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1431941\" data-linked=\"Workday beats by $0.05, beats on revenue\" data-tweet=\"$WDAY - Workday beats by $0.05, beats on revenue https://seekingalpha.com/news/1431941-workday-beats-by-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1431941-workday-beats-by-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431891\" data-ts=\"1385412664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431891-general-motors-to-hear-calls-for-dividends-and-buybacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Motors to hear calls for dividends and buybacks</a></h4><ul> <li>Shareholders of General Motors (<a href=\"https://seekingalpha.com/symbol/GM\" title=\"General Motors Company\">GM</a> <font color=\"green\">+0.1%</font>) will expect <a href=\"http://www.autonews.com/article/20131125/OEM/131129904/gm-investors-expect-buybacks-dividend-after-u-s-exit#axzz2lfjhqdvx\" target=\"_blank\">buybacks and dividends</a> in 2014 after the automaker finally sees the Treasury Department exit its position, says Barclays in a fresh research note.</li> <li>Execs have been tight-lipped on the subject, preferring to place the focus on investing in the company's growth. The company also still has to buy back the stake in GM held by the Canadian government before it can go too far down the capital allocation track.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1431891\" data-linked=\"General Motors to hear calls for dividends and buybacks\" data-tweet=\"$GM - General Motors to hear calls for dividends and buybacks https://seekingalpha.com/news/1431891-general-motors-to-hear-calls-for-dividends-and-buybacks?source=tweet\" data-url=\"https://seekingalpha.com/news/1431891-general-motors-to-hear-calls-for-dividends-and-buybacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431851\" data-ts=\"1385411262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431851-hunger-games-redux-hollywood-did-just-fine-but-wall-streets-aim-was-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hunger Games redux: Hollywood did just fine but Wall Street&#39;s aim was off</a></h4><ul> <li>Lions Gate (LGF <font color=\"red\">-10.3%</font>) is down sharply on volume 4X normal trading activity as massive box office success for the <i>Hunger Games: Catching Fire</i> wasn't enough to exceed the even larger expectations that were apparently baked into LGF's stock price.</li> <li>Analysts are out with some <a href=\"http://www.foxbusiness.com/industries/2013/11/25/hunger-games-sequel-fails-to-catch-fire/\" target=\"_blank\">pithy analysis</a> on the global potential of HG and more box office breakdowns which don't seem to be nudging sentiment.</li>\n<li>10 of 12 investment firms covering the movie studio concern have a solid Buy rating (no Sells) on LGF which they backed right through the HG premiere.</li>\n<li>B Riley says it's \"very comfortable\" with a gigantic $900M global box office estimate for the movie, but until momentum straightens out the knife could still be falling.</li> <li>\n<a href=\"https://seekingalpha.com/currents/search?query=hunger%20games\" target=\"_blank\">Hunger Games timeline</a> on SA</li> </ul><div class=\"tiny-share-widget\" data-id=\"1431851\" data-linked=\"Hunger Games redux: Hollywood did just fine but Wall Street&#39;s aim was off\" data-tweet=\"$LGF.A - Hunger Games redux: Hollywood did just fine but Wall Street&#39;s aim was off https://seekingalpha.com/news/1431851-hunger-games-redux-hollywood-did-just-fine-but-wall-streets-aim-was-off?source=tweet\" data-url=\"https://seekingalpha.com/news/1431851-hunger-games-redux-hollywood-did-just-fine-but-wall-streets-aim-was-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431811\" data-ts=\"1385409821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMF\" target=\"_blank\">OMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431811-springleaf-garners-a-handful-of-buy-ratings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Springleaf garners a handful of Buy ratings</a></h4><ul>\n<li>It's coverage initiation day for Springleaf Holdings (<a href=\"https://seekingalpha.com/symbol/LEAF\" title=\"Leaf Group Ltd.\">LEAF</a> <font color=\"green\">+2.9%</font>), and the subprime consumer lender notches four Buy ratings - from Credit Suisse, Barclays, Citi, and KBW. BAML stands apart from the pack, starting the company at a Hold. KBW has the highest price target at $26 while BAML is at $21.50.</li>\n<li>The stock's <font color=\"green\">ahead by 30%</font> since the mid-October IPO.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431811\" data-linked=\"Springleaf garners a handful of Buy ratings\" data-tweet=\"$OMF - Springleaf garners a handful of Buy ratings https://seekingalpha.com/news/1431811-springleaf-garners-a-handful-of-buy-ratings?source=tweet\" data-url=\"https://seekingalpha.com/news/1431811-springleaf-garners-a-handful-of-buy-ratings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431791\" data-ts=\"1385409156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431791-venaxis-rallies-craig-hallum-reportedly-sees-big-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Venaxis rallies, Craig-Hallum reportedly sees big upside</a></h4><ul>\n<li>Shares of Venaxis (APPY <font color=\"green\">+12%</font>) are notably higher on the session.</li>\n<li>Apparently helping the cause are analysts at Craig-Hallum, who are <a href=\"https://twitter.com/financialjuice/status/405057404003692544\" target=\"_blank\">reportedly out</a> with a $4 price target on the shares, representing upside of just under <font color=\"green\">141%</font> from Friday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431791\" data-linked=\"Venaxis rallies, Craig-Hallum reportedly sees big upside\" data-tweet=\"$RIOT - Venaxis rallies, Craig-Hallum reportedly sees big upside https://seekingalpha.com/news/1431791-venaxis-rallies-craig-hallum-reportedly-sees-big-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/1431791-venaxis-rallies-craig-hallum-reportedly-sees-big-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431771\" data-ts=\"1385408783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUDC\" target=\"_blank\">AUDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431771-audiocodes-higher-after-announcing-dell-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AudioCodes higher after announcing Dell partnership</a></h4><ul>\n<li>Dell's services arm will rely on AudioCodes' (<a href=\"https://seekingalpha.com/symbol/AUDC\" title=\"AudioCodes Ltd.\">AUDC</a> <font color=\"green\">+3.6%</font>) VoIP hardware/software to enable deployments of Microsoft's <a href=\"http://office.microsoft.com/en-us/lync/\" target=\"_blank\">Lync</a> unified communications software platform. (PR)</li>\n<li>Both <a href=\"https://seekingalpha.com/currents/post/1251742\" target=\"_blank\">analysts</a> and <a href=\"https://seekingalpha.com/currents/post/809091\" target=\"_blank\">SA contributors</a> have highlighted the potential of Lync deployments to act as a growth driver for AudioCodes.</li>\n<li>Shares <a href=\"https://seekingalpha.com/currents/post/1370372\" target=\"_blank\">fell hard</a> on Oct. 30 following AudioCodes' Q3 report, but are still <font color=\"green\">up 87%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431771\" data-linked=\"AudioCodes higher after announcing Dell partnership\" data-tweet=\"$AUDC - AudioCodes higher after announcing Dell partnership https://seekingalpha.com/news/1431771-audiocodes-higher-after-announcing-dell-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/1431771-audiocodes-higher-after-announcing-dell-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431741\" data-ts=\"1385408177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431741-salesforce-lower-after-analyst-calls-company-his-best-short-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce lower after analyst calls company his &quot;best short idea&quot;</a></h4><ul>\n<li>Arete Research's <a href=\"http://www.streetinsider.com/Analyst+Comments/Salesforce+%28CRM%29+Called+Best+Short+Idea+by+Analyst/8922575.html\" target=\"_blank\">Adam Shepherd</a> is reiterating a Sell and $24 PT on Salesforce (<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"red\">-3.3%</font>), while declaring the cloud CRM software giant his \"best short idea.\"</li>\n<li>Shepherd thinks Salesforce's core software growth is slowing, and that the company is relying on newly-acquired ExactTarget to hit estimates/guidance. He's also worried about Salesforce's <a href=\"https://seekingalpha.com/currents/post/1419212\" target=\"_blank\">aggressive spending</a> and cash flow pressures.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1420991\" target=\"_blank\">Concerns</a> about spending and operating leverage already led Salesforce to sell off last week following its FQ3 report.</li>\n<li>A few other enterprise cloud software names are also selling off on a bad day for tech momentum plays.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431741\" data-linked=\"Salesforce lower after analyst calls company his &quot;best short idea&quot;\" data-tweet=\"$CRM - Salesforce lower after analyst calls company his &quot;best short idea&quot; https://seekingalpha.com/news/1431741-salesforce-lower-after-analyst-calls-company-his-best-short-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/1431741-salesforce-lower-after-analyst-calls-company-his-best-short-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431721\" data-ts=\"1385407665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431721-sears-denies-eddie-is-chatting-up-bankers-on-sears-canada\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears denies Eddie is chatting up bankers on Sears Canada</a></h4><ul> <li>Sears Holdings (SHLD <font color=\"green\">+5.9%</font>) says a <a href=\"https://seekingalpha.com/currents/post/1431291\" target=\"_blank\">report</a> from earlier today on an initial sale process for Sears Canada is <a href=\"http://searsholdings.mediaroom.com/index.php?s=16310&amp;item=137251\" target=\"_blank\">false</a>.</li> <li>Investors aren't in a selling panic over the retailer's denial as it looks as if a little wordsmithing just might be in play.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1431721\" data-linked=\"Sears denies Eddie is chatting up bankers on Sears Canada\" data-tweet=\"$SHLDQ - Sears denies Eddie is chatting up bankers on Sears Canada https://seekingalpha.com/news/1431721-sears-denies-eddie-is-chatting-up-bankers-on-sears-canada?source=tweet\" data-url=\"https://seekingalpha.com/news/1431721-sears-denies-eddie-is-chatting-up-bankers-on-sears-canada\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431711\" data-ts=\"1385407239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431711-antibiotic-candidate-meets-endpoint-cubist-rallies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antibiotic candidate meets endpoint, Cubist rallies</a></h4><ul>\n<li>Cubist Pharmaceuticals (CBST <font color=\"green\">+8.9%</font>) posts solid gains after announcing that ceftolozane/tazobactam met its primary endpoint (non-inferiority to levofloxacin) in a pivotal Phase 3 study of patients with cUTIs.</li>\n<li>The company expcets Phase 3 cIAI data next month, and will use results from both studies to file for approval in both indications. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431711\" data-linked=\"Antibiotic candidate meets endpoint, Cubist rallies\" data-tweet=\"$MRK - Antibiotic candidate meets endpoint, Cubist rallies https://seekingalpha.com/news/1431711-antibiotic-candidate-meets-endpoint-cubist-rallies?source=tweet\" data-url=\"https://seekingalpha.com/news/1431711-antibiotic-candidate-meets-endpoint-cubist-rallies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431691\" data-ts=\"1385407043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBNT\" target=\"_blank\">UBNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431691-ubiquiti-slumps-after-disclosing-marketing-chiefs-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ubiquiti slumps after disclosing marketing chief&#39;s departure</a></h4><ul>\n<li>David Hsieh, Ubiquiti's (<a href=\"https://seekingalpha.com/symbol/UBNT\" title=\"Ubiquiti Networks, Inc.\">UBNT</a> <font color=\"red\">-8.1%</font>) chief marketing officer, left the company last Friday. (<a href=\"http://biz.yahoo.com/e/131122/ubnt8-k.html\" target=\"_blank\">8-K</a>)</li>\n<li>With shares <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1385044200000&amp;chddm=125266&amp;chls=IntervalBasedLine&amp;q=NASDAQ:UBNT&amp;ntsp=1&amp;ei=dKGTUtDZEeWtiQLIQA\" target=\"_blank\">up nearly 5x</a> from their Aug. '12 bottom prior to the disclosure, some investors may be looking for a reason to take profits. Ubiqiti <a href=\"https://seekingalpha.com/currents/post/1426161\" target=\"_blank\">rallied last Thursday</a> after BofA/Merrill hiked its PT to $50, and flew higher earlier in the month due to <a href=\"https://seekingalpha.com/currents/post/1400592\" target=\"_blank\">good earnings news</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431691\" data-linked=\"Ubiquiti slumps after disclosing marketing chief&#39;s departure\" data-tweet=\"$UBNT $UI - Ubiquiti slumps after disclosing marketing chief&#39;s departure https://seekingalpha.com/news/1431691-ubiquiti-slumps-after-disclosing-marketing-chiefs-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/1431691-ubiquiti-slumps-after-disclosing-marketing-chiefs-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431671\" data-ts=\"1385406663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431671-tg-therapeutics-initiates-study-of-ublituximab-pi3k-delta-inhibitor-combo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics initiates study of ublituximab/ PI3K Delta inhibitor combo</a></h4><ul>\n<li>TG Therapeutics (<a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a> <font color=\"green\">+10.4%</font>) jumps after announcing the initiation of a Phase 1 trial to test the efficacy and safety of a TG-1101/ TGR-1202 combo in  relapsed and/or refractory CLL and NHL.</li>\n<li>In other company news, TGTX opens the first expansion cohort in a TGR-1202 dose escalation study \u2014 no MTD has yet been determined. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431671\" data-linked=\"TG Therapeutics initiates study of ublituximab/ PI3K Delta inhibitor combo\" data-tweet=\"$TGTX - TG Therapeutics initiates study of ublituximab/ PI3K Delta inhibitor combo https://seekingalpha.com/news/1431671-tg-therapeutics-initiates-study-of-ublituximab-pi3k-delta-inhibitor-combo?source=tweet\" data-url=\"https://seekingalpha.com/news/1431671-tg-therapeutics-initiates-study-of-ublituximab-pi3k-delta-inhibitor-combo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431651\" data-ts=\"1385406189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431651-immunocellular-soars-on-hope-for-ictminus-107\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular soars on hope for ICT-107</a></h4><ul>\n<li>ImmunoCellular Therapeutics (<a href=\"https://seekingalpha.com/symbol/IMUC\" title=\"ImmunoCellular Therapeutics, Ltd.\">OTCPK:IMUC</a> <font color=\"green\">+22.9%</font>) rallies hard after Cedars-Sinai provides an update on a study of <a href=\"https://seekingalpha.com/currents/search?query=ICT-107\" target=\"_blank\">ICT-107</a> in glioblastoma multiforme.</li>\n<li>Eight of sixteen patients survived for longer than five years post-diagnosis.</li>\n<li>Six patients were progression free at five years.</li>\n<li>Four patients are still free of disease with \"good quality of life at lengths from 65.1-82.7 months following diagnosis.\" (PR)</li>\n<li>As for the Street's take: Roth <a href=\"https://twitter.com/thenotablecalls/status/404981211329601536\" target=\"_blank\">adds</a> IMUC to its Focus List. Price target is $9.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431651\" data-linked=\"ImmunoCellular soars on hope for ICT-107\" data-tweet=\"$IMUC - ImmunoCellular soars on hope for ICT-107 https://seekingalpha.com/news/1431651-immunocellular-soars-on-hope-for-ictminus-107?source=tweet\" data-url=\"https://seekingalpha.com/news/1431651-immunocellular-soars-on-hope-for-ictminus-107\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431581\" data-ts=\"1385405057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STML\" target=\"_blank\">STML</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431581-stemline-rallies-after-outlining-results-from-additional-vaccine-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stemline rallies after outlining results from additional vaccine study</a></h4><ul>\n<li>Stemline Therapeutics (<a href=\"https://seekingalpha.com/symbol/STML\" title=\"Stemline Therapeutics\">STML</a> <font color=\"green\">+11.6%</font>) enjoys a strong session after announcing late Friday evening that the results of a clinical trial of SL-701 in low-grade glioma were being presented at a Meeting of the World Federation of Neuro-Oncology.</li>\n<li>The company says an abstract shows the vaccine is \"well-tolerated and induced specific and sustained immune responses  against its brain tumor targets.\"</li>\n<li>Additionally, STML says the results show \"patients with a high magnitude  of immunologic responsiveness experienced prolonged progression free  survival.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431581\" data-linked=\"Stemline rallies after outlining results from additional vaccine study\" data-tweet=\"$STML - Stemline rallies after outlining results from additional vaccine study https://seekingalpha.com/news/1431581-stemline-rallies-after-outlining-results-from-additional-vaccine-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1431581-stemline-rallies-after-outlining-results-from-additional-vaccine-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431511\" data-ts=\"1385403474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431511-sunedison-planning-solar-project-ipo-shares-pare-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunEdison planning solar project IPO, shares pare losses</a></h4><ul>\n<li>SunEdison (SUNE <font color=\"red\">-1.6%</font>) CFO Brian Wuebbels tells Reuters his company <a href=\"http://www.reuters.com/article/2013/11/25/us-sunedison-ipo-idUSBRE9AO0QA20131125\" target=\"_blank\">plans to sell</a> a 20%-30% stake in a solar project subsidiary through a U.S. IPO that could raise up to $300M for financing new projects. The offering currently has a Q2 2014 ETA.</li>\n<li>The subsidiary, called SunEdison Yield Co, would own projects in the U.S., U.K., Japan, Canada, Mexico, and Chile, and likely pay a quarterly dividend. Wuebbels think Yield Co. would likely have $40M-$60M in distributable cash flow.</li>\n<li>SunEdison is also thinking of doing a Hong Kong or Singapore IPO for its Asian and South African solar projects If it happens, that offering would follow the U.S. IPO by a few months.</li>\n<li>Both prospective IPOs are separate from the <a href=\"https://seekingalpha.com/currents/post/1266632\" target=\"_blank\">$250M offering</a> SunEdison is planning for its chip wafer ops.</li>\n<li>Down over 4% earlier today, shares have pared their losses following Wuebbels' remarks. They took off earlier this month after SunEdison provided <a href=\"https://seekingalpha.com/currents/post/1389902\" target=\"_blank\">strong Q3 numbers</a> and Q4 guidance, and raise the possibility of spinning off some of its solar assets.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431511\" data-linked=\"SunEdison planning solar project IPO, shares pare losses\" data-tweet=\"$SUNEQ - SunEdison planning solar project IPO, shares pare losses https://seekingalpha.com/news/1431511-sunedison-planning-solar-project-ipo-shares-pare-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/1431511-sunedison-planning-solar-project-ipo-shares-pare-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431461\" data-ts=\"1385401958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431461-yelp-tumbles-topeka-worried-about-competition-from-facebook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp tumbles, Topeka worried about competition from Facebook</a></h4><ul>\n<li>On a rough day for Internet momentum stocks, Yelp (<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a> <font color=\"red\">-7.6%</font>) is the biggest decliner. A Topeka note <a href=\"https://twitter.com/thenotablecalls/status/405024971346288640\" target=\"_blank\">raising concerns</a> about Facebook's efforts to encroach on Yelp's turf could be playing a role.</li>\n<li>Worries about competition from Facebook are nothing new for Yelp; shares fell hard earlier <a href=\"https://seekingalpha.com/currents/post/763041\" target=\"_blank\">in January</a> after Facebook showed off Graph Search, and more moderately <a href=\"https://seekingalpha.com/currents/post/724631\" target=\"_blank\">the prior month</a> after Facebook updated its Nearby feature to provide a list of local businesses a user might be interested in.</li>\n<li>But Yelp's local reviews leadership, and the <a href=\"http://en.wikipedia.org/wiki/Network_effect\" target=\"_blank\">network effect</a> stemming from it, have helped keep Facebook (and Google) from doing serious damage thus far.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431461\" data-linked=\"Yelp tumbles, Topeka worried about competition from Facebook\" data-tweet=\"$YELP - Yelp tumbles, Topeka worried about competition from Facebook https://seekingalpha.com/news/1431461-yelp-tumbles-topeka-worried-about-competition-from-facebook?source=tweet\" data-url=\"https://seekingalpha.com/news/1431461-yelp-tumbles-topeka-worried-about-competition-from-facebook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431431\" data-ts=\"1385401577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431431-midday-gainers-losesr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losesr</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CAMT\" title=\"Camtek Ltd.\">CAMT</a> <font color=\"green\">+80%</font>. PBMD <font color=\"green\">+53%</font>. <a href=\"https://seekingalpha.com/symbol/ESMC\" title=\"Escalon Medical Corp.\">OTC:ESMC</a> <font color=\"green\">+31%</font>. <a href=\"https://seekingalpha.com/symbol/IMUC\" title=\"ImmunoCellular Therapeutics, Ltd.\">OTCPK:IMUC</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/HNR\" title=\"Harvest Natural Resources, Inc.\">HNR</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/ADEP\" title=\"Adept Technology, Inc.\">ADEP</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/GIG\" title=\"GigPeak, Inc.\">GIG</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/ANIP\" title=\"ANI Pharmaceuticals, Inc.\">ANIP</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/EDN\" title=\"Empresa Distribuidora y Comercializadora Norte S.A.\">EDN</a> <font color=\"green\">+15%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/ICLD-OLD\" title=\"InterCloud Systems, Inc.\">ICLD</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/ATRM\" title=\"Aetrium Incorporated\">OTC:ATRM</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/RCON\" title=\"Recon Technology, Ltd.\">RCON</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/ERB\" title=\"ERBA Diagnostics, Inc.\">ERB</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/AZC\" title=\"Augusta Resource Corporation\">AZC</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/OSUR\" title=\"OraSure Technologies, Inc.\">OSUR</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/MBIS\" title=\"Mediabistro Inc.\">MBIS</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/MTEX\" title=\"Mannatech, Incorporated\">MTEX</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/DQ\" title=\"DAQO New Energy Corp.\">DQ</a> <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1431431\" data-linked=\"Midday Gainers / Losesr\" data-tweet=\"$CAMT $IMMP $ESMC - Midday Gainers / Losesr https://seekingalpha.com/news/1431431-midday-gainers-losesr?source=tweet\" data-url=\"https://seekingalpha.com/news/1431431-midday-gainers-losesr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431421\" data-ts=\"1385401053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRGDF\" target=\"_blank\">DRGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431421-detour-gold-plummets-30-percent-as-ceo-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Detour Gold plummets 30% as CEO exits</a></h4><ul>\n<li>The surprise resignation of founder and CEO Gerald Panneton has sent Detour Gold (<a href=\"https://seekingalpha.com/symbol/DRGDF\" title=\"Detour Gold Corp.\">OTCPK:DRGDF</a> <font color=\"red\">-30.4%</font>) tumbling. He's been replaced on an interim basis by CFO Paul Martin.</li>\n<li>Martin: \u201cIt would be fair to say that none of us are satisfied with the share performance. What we need to do is to deliver on our operating parameters to improve that situation.\u201d</li>\n<li>RBC's Dan Rollins expects the company to move quickly to boost capital, but Martin says there's currently no thought of an equity raise.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431421\" data-linked=\"Detour Gold plummets 30% as CEO exits\" data-tweet=\"$DRGDF - Detour Gold plummets 30% as CEO exits https://seekingalpha.com/news/1431421-detour-gold-plummets-30-percent-as-ceo-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/1431421-detour-gold-plummets-30-percent-as-ceo-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431321\" data-ts=\"1385398445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCY\" target=\"_blank\">ONCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431321-a-confused-needham-maintains-buy-rating-on-oncolytics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A confused Needham maintains Buy rating on Oncolytics</a></h4><ul>\n<li>Although Needham's Chad Messer finds recent <a href=\"https://seekingalpha.com/currents/search?query=Reolysin\" target=\"_blank\">Reolysin</a> data to be \"confusing and <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Perplexed+by+Oncolytics+%28ONCY%29+H%26N+Trial+Data+Release+But+%27Staying+the+Course%27/8922340.html\" target=\"_blank\">hard to interpret</a> as reported,\" he is sticking with a Buy rating and an $8 price target on Oncolytics Biotech (<a href=\"https://seekingalpha.com/symbol/ONCY\" title=\"Oncolytics Biotech Inc.\">ONCY</a> <font color=\"red\">-2.3%</font>).<br>\n</li>\n<li>Rationale: \"We believe future publication of full results should help clear the air.  We continue to believe that the totality of available data supports  Reolysin activity and remind investors that we have multiple additional  data readouts in the near term.\"</li>\n<li>ONCY has had a tough go of it since releasing top-line data from a study of a <a href=\"https://seekingalpha.com/currents/search?query=Reolysin\" target=\"_blank\">Reolysin</a>/carboplatin/paclitaxel combo in second-line platinum-refractory, taxane-naïve head and  neck cancers last week.<br>\n</li>\n<li>For more on the results, including why some commentators raised questions, see <a href=\"https://seekingalpha.com/currents/post/1425831\" target=\"_blank\">here</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431321\" data-linked=\"A confused Needham maintains Buy rating on Oncolytics\" data-tweet=\"$ONCY - A confused Needham maintains Buy rating on Oncolytics https://seekingalpha.com/news/1431321-a-confused-needham-maintains-buy-rating-on-oncolytics?source=tweet\" data-url=\"https://seekingalpha.com/news/1431321-a-confused-needham-maintains-buy-rating-on-oncolytics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431291\" data-ts=\"1385397867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431291-sears-higher-following-canada-sale-report-but-whats-the-end-game\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears higher following Canada sale report, but what&#39;s the end-game?</a></h4><ul> <li>Shares of Sears Holdings (SHLD <font color=\"green\">+4.2%</font>) rally following a <a href=\"https://seekingalpha.com/currents/post/1430161\" target=\"_blank\">report</a> the company is lining up to sell Sears Canada.</li> <li>The development doesn't sound convincing to many retail analysts who question the wisdom of betting on a premium pricing for the business unit with Target, Wal-Mart, and Hudson's Bay all having their hands full in Canada.</li> <li>A more likely scenario could be more store closings and some cherry-picked asset sales to the major retail chains.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1431291\" data-linked=\"Sears higher following Canada sale report, but what&#39;s the end-game?\" data-tweet=\"$SHLDQ - Sears higher following Canada sale report, but what&#39;s the end-game? https://seekingalpha.com/news/1431291-sears-higher-following-canada-sale-report-but-whats-the-end-game?source=tweet\" data-url=\"https://seekingalpha.com/news/1431291-sears-higher-following-canada-sale-report-but-whats-the-end-game\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431281\" data-ts=\"1385397633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431281-jpmorgan-at-highest-since-dimon-took-over\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan at highest since Dimon took over</a></h4><ul>\n<li>More investigations please. JPMorgan (<a href=\"https://seekingalpha.com/symbol/JPM\" title=\"JPMorgan Chase &amp; Co.\">JPM</a> <font color=\"green\">+1%</font>) crosses $58 per share for the <a href=\"http://www.marketwatch.com/story/jp-morgan-at-highest-ever-level-under-dimon-2013-11-25?link=MW_home_latest_news\" target=\"_blank\">first time in Jamie Dimon's CEO tenure</a> (which began on Dec. 31, 2005). This compares to a $53.20 peak ahead of the financial crisis (the stock was in the 60s prior to the Internet bubble crash).</li>\n<li>More importantly, the recent run has brought the shares above their book value of $52.01. Bank of America, Citigroup, and Morgan Stanley remain below book, though Morgan is close to breaking through.</li>\n<li>In many ways, JPMorgan is better-run than before the financial crisis, says UBS' Derek De Vries, noting ROE of 18% for the year's first nine months compares to 12% during the same period in 2006 and 7% in 2005. Pointing to the rising dividend payout ratio (34% of earnings this year compared to 23% a year ago), RBS' Gerard Cassidy, says regulators won't let the bank do anything else with its money. \"If you were a high-tech stock ... being called a utility would kill the stock price ... but being a financial called a utility is very positive.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431281\" data-linked=\"JPMorgan at highest since Dimon took over\" data-tweet=\"$JPM - JPMorgan at highest since Dimon took over https://seekingalpha.com/news/1431281-jpmorgan-at-highest-since-dimon-took-over?source=tweet\" data-url=\"https://seekingalpha.com/news/1431281-jpmorgan-at-highest-since-dimon-took-over\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431271\" data-ts=\"1385397149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431271-questcor-falls-as-citron-says-ftc-investigation-looms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Questcor falls as Citron says FTC investigation looms</a></h4><ul><li>Questcor Pharmaceuticals (QCOR <font color='red'>-1.9%</font>) slides hard after Citron Research says the FTC is investigating the company's <a href=\"https://seekingalpha.com/currents/post/1076432\" target=\"_blank\">acquisition</a> of Synacthen, a synthetic version of the active ingredient in <a href=\"https://seekingalpha.com/currents/search?query=acthar\" target=\"_blank\">Acthar</a>.</li><li>Full report is <a href=\"http://www.citronresearch.com/wp-content/uploads/2013/11/Questcor-and-the-FTC-final.pdf\" target=\"_blank\">here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1431271\" data-linked=\"Questcor falls as Citron says FTC investigation looms\" data-tweet=\"$MNK - Questcor falls as Citron says FTC investigation looms https://seekingalpha.com/news/1431271-questcor-falls-as-citron-says-ftc-investigation-looms?source=tweet\" data-url=\"https://seekingalpha.com/news/1431271-questcor-falls-as-citron-says-ftc-investigation-looms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431211\" data-ts=\"1385395980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GA\" target=\"_blank\">GA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431211-giant-interactive-chairman-offers-to-take-company-private\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Giant Interactive chairman offers to take company private</a></h4><ul>\n<li>Giant Interactive (<a href=\"https://seekingalpha.com/symbol/GA\" title=\"Giant Interactive Group Inc.\">GA</a> <font color=\"green\">+11.5%</font>) founder/chairman Yuzhu Shi and P-E firm Baring Private Equity Asia have offered, through a preliminary non-binding proposal letter, to take the Chinese online game developer private for $11.75/share, or $2.8B. (PR)</li>\n<li>The price represents a 16% premium to Giant's Friday close, and a 4% premium to where shares currently trade. Shi and Baring collectively own 47.2% of Giant.</li>\n<li>Shi is <a href=\"https://seekingalpha.com/currents/post/146941\" target=\"_blank\">far from the first</a> founder of a Chinese tech company to make a going-private offer. His proposal values Giant at a little over 9x 2014E EPS after backing out $610M in cash/investments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431211\" data-linked=\"Giant Interactive chairman offers to take company private\" data-tweet=\"$GA - Giant Interactive chairman offers to take company private https://seekingalpha.com/news/1431211-giant-interactive-chairman-offers-to-take-company-private?source=tweet\" data-url=\"https://seekingalpha.com/news/1431211-giant-interactive-chairman-offers-to-take-company-private\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431151\" data-ts=\"1385395109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIN\" target=\"_blank\">HAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431151-select-food-sellers-having-a-rough-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select food sellers having a rough day</a></h4><ul> <li>A <a href=\"https://seekingalpha.com/currents/post/1429961\" target=\"_blank\">harsh read</a> on Campbell Soup's prospects from Goldman Sachs might be unsettling a few other food stocks on concerns they could be suffering from the same brand demand malaise.</li>  <li>Decliners: Hain Celestial (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HAIN\" title=\"The Hain Celestial Group, Inc.\">HAIN</a>) <font color=\"red\">-2.3%</font>, Annies (NYSE:<a href=\"https://seekingalpha.com/symbol/BNNY\" title=\"Annie's, Inc.\">BNNY</a>) <font color=\"red\">-1.5%</font>, Diamond Foods (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DMND\" title=\"Diamond Foods, Inc.\">DMND</a>) <font color=\"red\">-0.7%</font>, John B. Sanfiliipo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JBSS\" title=\"John B. Sanfilippo &amp; Son, Inc.\">JBSS</a>) <font color=\"red\">-1.3%</font>, The Fresh Market (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TFM\" title=\"The Fresh Market\">TFM</a>) <font color=\"red\">-1.2%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1431151\" data-linked=\"Select food sellers having a rough day\" data-tweet=\"$HAIN $HAIN $BNNY - Select food sellers having a rough day https://seekingalpha.com/news/1431151-select-food-sellers-having-a-rough-day?source=tweet\" data-url=\"https://seekingalpha.com/news/1431151-select-food-sellers-having-a-rough-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431081\" data-ts=\"1385394049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431081-ebay-falls-janney-worried-about-cyber-monday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">eBay falls; Janney worried about Cyber Monday sales</a></h4><ul><li><a href=\"https://twitter.com/SheilaD_TV/status/404985864708558848\" target=\"_blank\">Janney thinks</a> Cyber Monday same-store sales growth for eBay (<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a> <font color='red'>-3.6%</font>) merchants could be in the mid-to-high single-digit range. That would be notable worse than the same-store sales growth ChannelAdvisor (<a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='red'>-2%</font>) <a href=\"http://ebaystrategies.blogs.com/ebay_strategies/2013/11/october-2013-channeladvisor-same-store-sales-sss-for-ebay-amazon-search-and-cse.html\" target=\"_blank\">has been reporting</a> for its clients' eBay sales.</li><li>eBay missed Q3 revenue estimates and issued weaker-than-expected <a href=\"https://seekingalpha.com/currents/post/1332912\" target=\"_blank\">Q4 guidance</a> last month, and largely <a href=\"https://seekingalpha.com/currents/post/1333392\" target=\"_blank\">blamed it</a> on U.S. e-commerce softness. But the company later <a href=\"https://seekingalpha.com/currents/post/1338402\" target=\"_blank\">backtracked a bit</a> on its remarks.</li><li>Fears have been running high that eBay's Marketplaces ops are once more losing share to Amazon, which <a href=\"https://seekingalpha.com/currents/post/1354352\" target=\"_blank\">beat</a> its Q3 revenue estimates and offered relatively healthy Q4 top-line guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"1431081\" data-linked=\"eBay falls; Janney worried about Cyber Monday sales\" data-tweet=\"$EBAY $EBAY $ECOM - eBay falls; Janney worried about Cyber Monday sales https://seekingalpha.com/news/1431081-ebay-falls-janney-worried-about-cyber-monday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/1431081-ebay-falls-janney-worried-about-cyber-monday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431021\" data-ts=\"1385393214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431021-harsh-downgrade-for-jetblue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harsh downgrade for JetBlue</a></h4><ul> <li>JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='red'>-1.1%</font>) is <a href=\"http://www.cnbc.com/id/101224872\" target=\"_blank\">reduced</a> to an Underperform rating from Market Perform by Raymond James</li> <li>The investment firm thinks valuation is stretched out on the carrier after its +57% YTD run.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1431021\" data-linked=\"Harsh downgrade for JetBlue\" data-tweet=\"$JBLU - Harsh downgrade for JetBlue https://seekingalpha.com/news/1431021-harsh-downgrade-for-jetblue?source=tweet\" data-url=\"https://seekingalpha.com/news/1431021-harsh-downgrade-for-jetblue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1431001\" data-ts=\"1385392712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QIHU\" target=\"_blank\">QIHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1431001-qihoo-sells-off-in-spite-of-q3-beat-solid-guidance-stifel-cuts-to-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qihoo sells off in spite of Q3 beat, solid guidance; Stifel cuts to Hold</a></h4><ul>\n<li>In addition to beating Q3 estimates, Qihoo (<a href=\"https://seekingalpha.com/symbol/QIHU\" title=\"QIHOO 360 Technology Co. Ltd.\">QIHU</a> <font color=\"red\">-4%</font>) is guiding for Q4 revenue of $206M-$208M, above a $203M consensus.</li>\n<li>Nonetheless, with shares up 192% YTD going into the Q3 report, Stifel is cutting Qihoo to Hold. The firm, which has been bullish on Qihoo since the $20s, <a href=\"https://twitter.com/thenotablecalls/status/404959985718669312\" target=\"_blank\">thinks</a> the company's revenue growth will slow over the next two quarters thanks to policy changes at a top advertiser.</li>\n<li>Online ad revenue (64% of total revenue) rose 33% Q/Q and 107% Y/Y in Q3; the Y/Y clip is up from Q2's 78%, and has much to do with ramping search ad sales. Continued growth for Qihoo's browser home page also didn't hurt.</li>\n<li>Internet value-added services revenue (gaming-driven) rose 10% Q/Q and 163% Y/Y, after rising 33% Q/Q and 181% Y/Y in Q2.</li>\n<li>While revenue rose 124% Y/Y, opex rose 74%. Sales/marketing spend more than doubled to $28.1M, and R&amp;D spend surged 65% to $68.5M.</li>\n<li>Total monthly active users for Qihoo products only rose 1% Q/Q and 5% Y/Y to 465M, but growth for certain major products was much stronger. Smartphone users of Qihoo's 360 Mobile Safe security app rose 21% Q/Q and 173% Y/Y to 408M, and  daily unique visitors for the company's browser home page rose 11% Q/Q and 29% Y/Y to 126M.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1430121\" target=\"_blank\">Q3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1431001\" data-linked=\"Qihoo sells off in spite of Q3 beat, solid guidance; Stifel cuts to Hold\" data-tweet=\"$QIHU - Qihoo sells off in spite of Q3 beat, solid guidance; Stifel cuts to Hold https://seekingalpha.com/news/1431001-qihoo-sells-off-in-spite-of-q3-beat-solid-guidance-stifel-cuts-to-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/1431001-qihoo-sells-off-in-spite-of-q3-beat-solid-guidance-stifel-cuts-to-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430991\" data-ts=\"1385392612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430991-lions-gate-suffering-post-hunger-games-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate suffering post-Hunger Games sell-off</a></h4><ul> <li>Shares of Lions Gate (LGF <font color=\"red\">-8.3%</font>) are lower on what some retail analysts are calling post-Hunger Games panic selling. The stock has seen some wild intra-day momentum swings in the past before settling back to trade at premium enterprise value-to-sales multiples.</li> <li>By the numbers, Hollywood insiders say there's not much to argue with as Catching Fire lit up domestic and global box offices and set up the franchise quite nicely for the 3rd film. If there's a quibble, it's that expectations were sky-high for LGF.</li> <li>Another HG stock: IMAX (<a href=\"https://seekingalpha.com/symbol/IMAX\" title=\"IMAX Corporation\">IMAX</a>) broke out higher in the other direction after Catching Fire set a U.S. record for revenue per screen, but has settled back.</li> <li>Previous on Hunger Games: (<a href=\"https://seekingalpha.com/currents/post/1429891\" target=\"_blank\">weekend wrap</a>, <a href=\"https://seekingalpha.com/currents/post/1426521\" target=\"_blank\">early buzz</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1430991\" data-linked=\"Lions Gate suffering post-Hunger Games sell-off\" data-tweet=\"$LGF.A $LGF.A $IMAX - Lions Gate suffering post-Hunger Games sell-off https://seekingalpha.com/news/1430991-lions-gate-suffering-post-hunger-games-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/1430991-lions-gate-suffering-post-hunger-games-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430951\" data-ts=\"1385392049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVA\" target=\"_blank\">DVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430951-davita-healthcare-talks-cms-esrd-rates-gives-2014-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DaVita HealthCare talks CMS ESRD rates, gives 2014 guidance</a></h4><ul>\n<li>\"The good news is that Medicare rates will not be decreased next year,       when most thought rates would be down,\" DaVita HealthCare's (<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a> <font color=\"green\">+6.6%</font>) group VP LeAnne Zumwalt says, reacting to the final CMS Medicare ESRD rule for       2014.</li>\n<li>\"The       bad news is ... that Medicare dialysis       rates will be flat in 2014 and 2015 in an environment of increasing       expenses,\" Zumwalt adds.<br>\n</li>\n<li>In light of the rule, DVA provides the following guidance for FY14: Enterprise       operating income, $1.675-1.85B; operating income for dialysis services and       related ancillary businesses, $1.425 to $1.54B; operating income for HCP, $250 to $310M. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430951\" data-linked=\"DaVita HealthCare talks CMS ESRD rates, gives 2014 guidance\" data-tweet=\"$DVA - DaVita HealthCare talks CMS ESRD rates, gives 2014 guidance https://seekingalpha.com/news/1430951-davita-healthcare-talks-cms-esrd-rates-gives-2014-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1430951-davita-healthcare-talks-cms-esrd-rates-gives-2014-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430891\" data-ts=\"1385391056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430891-aegis-still-positive-on-cytrx-sees-big-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegis still positive on CytRx, sees big upside</a></h4><ul>\n<li>Aegis is out with some <a href=\"http://www.streetinsider.com/Analyst+Comments/Positive+Indicators+Ahead+for+CytRx+%28CYTR%29%2C+Aegis+Maintains+Buy/8921448.html\" target=\"_blank\">upbeat commentary</a> on CytRx (<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a> <font color=\"green\">+3%</font>), noting that despite the appearance of \"a higher incidence of adverse events on <a href=\"https://seekingalpha.com/currents/search?query=aldoxorubicin\" target=\"_blank\">aldoxorubicin</a> ... all grade 3 or 4 thrombocytopenia, mucositis, or nausea / vomiting events are manageable and resolve.\"</li>\n<li>As for the PFS outlook for aldoxorubicin, analyst Ram Selvaraju says \"numbers of patients completing either four or six cycles both favor\" the drug which, when \"coupled with the 22%  versus 0% PR rate favoring aldox may be predictive of positive  PFS data.\"</li>\n<li>Price target is $7 (so, upside of <font color=\"green\">200%+</font> from Friday's close).</li>\n<li>For more on the data Selvaraju is referencing, see <a href=\"https://seekingalpha.com/currents/post/1374262\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430891\" data-linked=\"Aegis still positive on CytRx, sees big upside\" data-tweet=\"$CYTR - Aegis still positive on CytRx, sees big upside https://seekingalpha.com/news/1430891-aegis-still-positive-on-cytrx-sees-big-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/1430891-aegis-still-positive-on-cytrx-sees-big-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430851\" data-ts=\"1385390197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOL\" target=\"_blank\">AOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430851-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>AOL (<a href='https://seekingalpha.com/symbol/AOL' title='AOL Inc.'>AOL</a> <font color='red'>-1.2%</font>) has been cut to Sector Perform by RBC.</li><li>Brocade (<a href='https://seekingalpha.com/symbol/BRCD' title='Brocade Communications Systems, Inc.'>BRCD</a> <font color='red'>-1.6%</font>) has been cut to Neutral by ISI.</li><li>CommVault (<a href='https://seekingalpha.com/symbol/CVLT' title='CommVault Systems, Inc.'>CVLT</a> <font color='green'>+2.2%</font>) has been started at Buy by Monness Crespi.</li><li>Gigoptix (<a href='https://seekingalpha.com/symbol/GIG' title='GigPeak, Inc.'>GIG</a> <font color='green'>+16.1%</font>) has been started at Buy by Roth.</li></ul><div class=\"tiny-share-widget\" data-id=\"1430851\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$AOL $AOL $BRCD - A roundup of tech ratings changes https://seekingalpha.com/news/1430851-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1430851-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430841\" data-ts=\"1385390172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430841-philippine-shares-struggle-protests-continue-in-thailand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Philippine shares struggle, protests continue in Thailand</a></h4><ul>\n<li>Philippine shares (<a href=\"https://seekingalpha.com/symbol/ephe\" title=\"iShares MSCI Philippines ETF\">EPHE</a>) underperform regional markets, falling <font color=\"red\">1.3%</font> in Manila on $11.8M in foreign selling (<a href=\"http://www.reuters.com/article/2013/11/25/markets-southeastasia-stocks-idUSL4N0JA0N020131125\" target=\"_blank\">Reuters</a>).</li>\n<li>Meanwhile, Thai shares (<a href=\"https://seekingalpha.com/symbol/thd\" title=\"iShares MSCI Thailand Capped ETF\">THD</a>, <a href=\"https://seekingalpha.com/symbol/tf\" title=\"Thai Capital Fund\">TF</a>, <a href=\"https://seekingalpha.com/symbol/ttf\" title=\"Thai Fund\">TTF</a>) close lower by <font color=\"red\">0.5%</font> after bouncing off morning and mid-afternoon lows.</li>\n<li>Weighing on investor psychology in Thailand are tens of thousands of protesters who have <a href=\"http://www.bbc.co.uk/news/world-asia-25084013\" target=\"_blank\">taken to the streets</a> in recent days to express their disapproval for Prime Minister Yingluck Shinawatra's government.</li>\n<li>The political discord is tied to an amnesty bill which, although struck down in the Senate, hit a nerve with many Thai citizens.</li>\n<li>For more on the amnesty bill see <a href=\"https://seekingalpha.com/currents/search?query=amnesty+bill+Thai\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430841\" data-linked=\"Philippine shares struggle, protests continue in Thailand\" data-tweet=\"$EPHE $THD $TF-OLD - Philippine shares struggle, protests continue in Thailand https://seekingalpha.com/news/1430841-philippine-shares-struggle-protests-continue-in-thailand?source=tweet\" data-url=\"https://seekingalpha.com/news/1430841-philippine-shares-struggle-protests-continue-in-thailand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430741\" data-ts=\"1385388876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMT\" target=\"_blank\">CAMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430741-camtek-surges-33_6-percent-pre-market-on-bull-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camtek surges 33.6% pre-market on bull case</a></h4><ul>\n<li>Camtek (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAMT\" title=\"Camtek Ltd.\">CAMT</a>) <font color=\"green\">surges 33.6%</font> pre-market on heavy volume, adding to Friday's <font color=\"green\">39.5% gain</font>.</li>\n<li>The most probable cause of the move? A <a href=\"https://seekingalpha.com/article/1860761-camtek-ltd-to-launch-first-of-its-kind-3-d-printer\" target=\"_blank\">bull argument </a>by SA contributor super-trades which claims that the stock should be considered a 3D printing play given the company's planned 2014 roll out of a commercial 3D printer that manufactures Printed Circuit Boards. The author calls it \"the world's first.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430741\" data-linked=\"Camtek surges 33.6% pre-market on bull case\" data-tweet=\"$CAMT - Camtek surges 33.6% pre-market on bull case https://seekingalpha.com/news/1430741-camtek-surges-33_6-percent-pre-market-on-bull-case?source=tweet\" data-url=\"https://seekingalpha.com/news/1430741-camtek-surges-33_6-percent-pre-market-on-bull-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430681\" data-ts=\"1385387929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430681-progenics-to-relaunch-azedra-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics to relaunch Azedra study</a></h4><ul>\n<li>Progenics Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a>) rallies <font color=\"green\">7% </font>before the bell.</li>\n<li>The company is restarting a Phase 2b study of Azedra in pheochromocytomas.</li>\n<li>Molecular Insight Pharmaceuticals suspended the trial back in 2010 in order to find more funding. PGNX acquired the company earlier this year.</li>\n<li>Once the study is complete, PGNX says it \"intends to submit a NDA and request priority review to receive FDA action on the application within six months instead of the standard ten.\"</li>\n<li>Azedra has Orphan Drug and Fast Track designations. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430681\" data-linked=\"Progenics to relaunch Azedra study\" data-tweet=\"$PGNX - Progenics to relaunch Azedra study https://seekingalpha.com/news/1430681-progenics-to-relaunch-azedra-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1430681-progenics-to-relaunch-azedra-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430631\" data-ts=\"1385387081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430631-ariad-pharmaceuticals-looks-to-extend-fridays-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad Pharmaceuticals looks to extend Friday&#39;s rally</a></h4><ul>\n<li>Ariad Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>) is trading higher by <font color=\"green\">10% </font>in premarket action.</li>\n<li>The shares are looking build on Friday's <a href=\"https://seekingalpha.com/currents/post/1428051\" target=\"_blank\">big rally</a>, which was sparked by a bit of much needed good news for <a href=\"https://seekingalpha.com/currents/search?query=iclusig\" target=\"_blank\">Iclusig</a> courtesy of the CHMP.</li>\n<li>Market chatter <a href=\"https://twitter.com/CaptainFuture__/status/404950924935692288\" target=\"_blank\">suggests</a> BMO has upped their price target on the shares to $4 from $2.50.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430631\" data-linked=\"Ariad Pharmaceuticals looks to extend Friday&#39;s rally\" data-tweet=\"$ARIA - Ariad Pharmaceuticals looks to extend Friday&#39;s rally https://seekingalpha.com/news/1430631-ariad-pharmaceuticals-looks-to-extend-fridays-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1430631-ariad-pharmaceuticals-looks-to-extend-fridays-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430621\" data-ts=\"1385386800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430621-wal-mart-names-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wal-Mart names new CEO</a></h4><ul> <li>Wal-Mart (NYSE:<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a>) announces Doug McMillon will replace Mike Duke as CEO of the company on February 1, 2014.</li> <li>The naming of the veteran exec to replace Duke wasn't a major surprise, but is giving shares a little boost in early trade.</li>\n<li>McMillon has manned Wal-Mart International most recently.</li> <li>WMT <font color=\"green\">+0.8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1430621\" data-linked=\"Wal-Mart names new CEO\" data-tweet=\"$WMT - Wal-Mart names new CEO https://seekingalpha.com/news/1430621-wal-mart-names-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/1430621-wal-mart-names-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430611\" data-ts=\"1385386580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430611-8x8-plus-2_9-percent-amid-buy-ratings-insider-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">8x8 +2.9% amid Buy ratings, insider purchase</a></h4><ul>\n<li>There's more insider buying activity at 8x8 (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EGHT\" title=\"8X8 Inc\">EGHT</a>) with CEO Verma Vikram <a href=\"http://www.sec.gov/Archives/edgar/data/1023731/000102373113000090/xslF345X03/primary_doc.xml\" target=\"_blank\">picking up 25K shares</a> at $9.49 on Friday.</li>\n<li>The stock also gets some love from the sell side with Barclays, BAML, and Deutsche all initiating with Buys.</li>\n<li>\"We believe the company <a href=\"http://www.streetinsider.com/New+Coverage/Deutsche+Bank+Starts+8x8+%28EGHT%29+at+Buy/8921278.html\" target=\"_blank\">benefits from the early stages</a> of a cloud replacement cycle in their core telephony and contact center markets, and recent investments to go up-market will pay dividends over time,\" says Deutsche's Nandan Amladi.</li>\n<li>Shares <font color=\"green\">+2.9%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430611\" data-linked=\"8x8 +2.9% amid Buy ratings, insider purchase\" data-tweet=\"$EGHT - 8x8 +2.9% amid Buy ratings, insider purchase https://seekingalpha.com/news/1430611-8x8-plus-2_9-percent-amid-buy-ratings-insider-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/1430611-8x8-plus-2_9-percent-amid-buy-ratings-insider-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430601\" data-ts=\"1385386531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KZIA\" target=\"_blank\">KZIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430601-novogen-says-trilexium-shows-promise-in-mouse-model-of-ovarian-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novogen says Trilexium shows promise in mouse model of ovarian cancer</a></h4><ul>\n<li>Novogen (NVGN) trades higher by <font color=\"green\">15%</font> premarket.</li>\n<li>The company says Trilexium (a lead drug candidate from subsidiary CanTx), \"is highly effective at destroying ovarian cancer spheroid architecture.\"</li>\n<li>Essentially, researchers isolated ovarian cancer stem cells, let them form self-renewing spheroids, then injected the spheroids into mice.</li>\n<li>Here's what the researchers had to say: \"Trilexium is the first drug in our hands that has been shown to penetrate and destroy the spheroid architecture. This observation demonstrates that Trilexium can diffuse into the spheroid  and gives us confidence that it should be able to kill ovarian cancer  tumors in vivo.\" (<a href=\"http://www.sec.gov/Archives/edgar/data/1075880/000119312513452091/d634185d6k.htm\" target=\"_blank\">6-K</a>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430601\" data-linked=\"Novogen says Trilexium shows promise in mouse model of ovarian cancer\" data-tweet=\"$KZIA - Novogen says Trilexium shows promise in mouse model of ovarian cancer https://seekingalpha.com/news/1430601-novogen-says-trilexium-shows-promise-in-mouse-model-of-ovarian-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/1430601-novogen-says-trilexium-shows-promise-in-mouse-model-of-ovarian-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430571\" data-ts=\"1385385977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KCG\" target=\"_blank\">KCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430571-kcg-boosted-to-buy-at-rayjay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KCG boosted to Buy at RayJay</a></h4><ul>\n<li>Citing Getco merger synergies, increased confidence in the Getco business, and expectations for buybacks once debt is payed down, <a href=\"http://www.streetinsider.com/Upgrades/Raymond+James+Upgrades+KCG+Holdings+%28KCG%29+to+Outperform/8921006.html\" target=\"_blank\">Raymond James upgrades</a> KCG Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/KCG\" title=\"KCG Holdings, Inc.\">KCG</a>) to Buy with $13 price target.</li>\n<li>Shares <font color=\"green\">+1.2%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430571\" data-linked=\"KCG boosted to Buy at RayJay\" data-tweet=\"$KCG - KCG boosted to Buy at RayJay https://seekingalpha.com/news/1430571-kcg-boosted-to-buy-at-rayjay?source=tweet\" data-url=\"https://seekingalpha.com/news/1430571-kcg-boosted-to-buy-at-rayjay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430551\" data-ts=\"1385385821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430551-feuerstein-comments-hit-ampio-in-early-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Feuerstein comments hit Ampio in early trading</a></h4><ul>\n<li>Ampio Pharmaceuticals (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/AMPE\" title=\"Ampio Pharmaceuticals, Inc.\">AMPE</a>) is trading <font color=\"red\">6.6%</font> lower premarket.</li>\n<li>Likely behind the move is <em>TheStreet</em>'s Adam Feuerstein who, in a response to <a href=\"https://seekingalpha.com/article/1859491-ampio-anticipating-data-for-exciting-dme-therapy-optina\" target=\"_blank\">an article</a> by SA contributor Brian Wilson, says the company \"<a href=\"http://www.thestreet.com/story/12123291/1/ampio-hides-need-for-new-eye-drug-study-in-sec-filing.html\" target=\"_blank\">slipped in</a>\" new disclosures regarding <a href=\"https://seekingalpha.com/currents/search?query=optina\" target=\"_blank\">Optina</a> in the prospectus for its most recent financing.</li>\n<li>According to Feuerstein, the company's disclosure that \"the FDA has previously indicated that a Phase 3 trial may be necessary following the current trial\" is quite a change of pace from the language present in AMPE's March 10-Q.</li>\n<li>\"The FDA has never approved a drug for DME based on a 12-week clinical trial,\" Feuerstein says.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430551\" data-linked=\"Feuerstein comments hit Ampio in early trading\" data-tweet=\"$AMPE - Feuerstein comments hit Ampio in early trading https://seekingalpha.com/news/1430551-feuerstein-comments-hit-ampio-in-early-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1430551-feuerstein-comments-hit-ampio-in-early-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430521\" data-ts=\"1385385387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMT\" target=\"_blank\">CAMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430521-camtek-parent-unaware-of-market-moving-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camtek parent unaware of market-moving news</a></h4><ul>\n<li>Camtek (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAMT\" title=\"Camtek Ltd.\">CAMT</a>) <font color=\"green\">pops another 22%</font> in premarket trade with parent company Priortech <a href=\"http://www.sec.gov/Archives/edgar/data/1109138/000117891313003382/zk1313982.htm\" target=\"_blank\">denying rumors</a> it's set to tender for the shares. The stock <font color=\"green\">gained 39.5%</font> on Friday.</li>\n<li>Apple over the weekend <a href=\"https://seekingalpha.com/currents/post/1429991\" target=\"_blank\">confirmed its acquisition</a> of PrimeSense for about $360M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430521\" data-linked=\"Camtek parent unaware of market-moving news\" data-tweet=\"$CAMT - Camtek parent unaware of market-moving news https://seekingalpha.com/news/1430521-camtek-parent-unaware-of-market-moving-news?source=tweet\" data-url=\"https://seekingalpha.com/news/1430521-camtek-parent-unaware-of-market-moving-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430511\" data-ts=\"1385384965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDX\" target=\"_blank\">CLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430511-celldex-falls-after-rindopepimut-interim-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celldex falls after rindopepimut interim data</a></h4><ul>\n<li>On Sunday, Celldex Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLDX\" title=\"Celldex Therapeutics, Inc\">CLDX</a>) reported interim data from ReACT.</li>\n<li>The company says the results \"demonstrate promising clinical activity\" in patients with brain cancer.</li>\n<li>So far, it appears investors are not impressed, as the shares are trading lower by <font color=\"red\">7%</font> in premarket action.</li>\n<li>Traders may be attempting to draw some conclusions about the <a href=\"https://seekingalpha.com/currents/search?query=rindopepimut\" target=\"_blank\">rindopepimut</a> study based on the reported p-values (as highlighted <a href=\"https://seekingalpha.com/currents/post/1429981\" target=\"_blank\">here</a> yesterday): OS, p=0.16; PFS, p=0.47.</li>\n<li>The stock will be on watch as a CC to discuss the results begins at 8:30 ET</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430511\" data-linked=\"Celldex falls after rindopepimut interim data\" data-tweet=\"$CLDX - Celldex falls after rindopepimut interim data https://seekingalpha.com/news/1430511-celldex-falls-after-rindopepimut-interim-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1430511-celldex-falls-after-rindopepimut-interim-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430411\" data-ts=\"1385383851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430411-orexigen-rallies-on-renewed-hope-for-contrave-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orexigen rallies on renewed hope for Contrave approval</a></h4><ul>\n<li>Orexigen Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OREX\" title=\"Orexigen Therapeutics, Inc.\">OREX</a>) rallies <font color=\"green\">19%</font> premarket.</li>\n<li>The company is out today with some commentary on an interim analysis from the Light Study which OREX says \"clearly achieved the goal set by the FDA.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/search?query=contrave\" target=\"_blank\"></a><em><a href=\"https://seekingalpha.com/currents/search?query=contrave\" target=\"_blank\">Contrave</a> NDA resubmission to come \"in the next few weeks.\"</em>\n</li>\n<li>Potential approval \"by June 2014.\"</li>\n<li>NDA will now contain \"an unprecedented amount of cardiovascular outcomes data.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430411\" data-linked=\"Orexigen rallies on renewed hope for Contrave approval\" data-tweet=\"$OREX - Orexigen rallies on renewed hope for Contrave approval https://seekingalpha.com/news/1430411-orexigen-rallies-on-renewed-hope-for-contrave-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/1430411-orexigen-rallies-on-renewed-hope-for-contrave-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430331\" data-ts=\"1385383152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430331-caterpillar-boosted-at-bofa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar boosted at BofA</a></h4><ul>\n<li>A struggling Caterpillar (NYSE:<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a>) gets a little love from Bank of America, which <a href=\"http://www.streetinsider.com/Hot+New+Coverage/BofAMerrill+Lynch+Upgrades+Caterpillar+%28CAT%29+to+Buy/8920938.html\" target=\"_blank\">boosts the stock</a> to Buy with $100 price target.</li>\n<li>Shares are <font color=\"green\">ahead 2.1% i</font>n the premarket, but <font color=\"red\">off 7.5%</font> YTD amid a major rally for the DJIA.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430331\" data-linked=\"Caterpillar boosted at BofA\" data-tweet=\"$CAT - Caterpillar boosted at BofA https://seekingalpha.com/news/1430331-caterpillar-boosted-at-bofa?source=tweet\" data-url=\"https://seekingalpha.com/news/1430331-caterpillar-boosted-at-bofa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430321\" data-ts=\"1385382816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430321-alcoa-raised-to-buy-at-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa raised to Buy at Goldman</a></h4><ul>\n<li>\"We believe that the market is not fully appreciating Alcoa's (NYSE:<a href=\"https://seekingalpha.com/symbol/AA\" title=\"Alcoa Corporation\">AA</a>) solid position in growing value-added and high margin aluminum products for the aerospace and automotive industries,\" <a href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Raises+Alcoa+%28AA%29+to+Buy/8920775.html\" target=\"_blank\">says analyst Sal Tharani</a>, boosting the stock to Buy with price target raised to $11 from $8. He sees Alcoa adding over $2B in revenue and $525M of EBITDA from end-market growth and share gains.</li>\n<li>Engineered products, he argues, are less aluminum price-sensitive and should provide upside even with a sluggish overall outlook for aluminum overall.</li>\n<li>Turning to expenses and productivity improvements, Tharani applauds management's efforts and sees positive free cash flow starting next year.</li>\n<li>Shares <font color=\"green\">+3%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1430321\" data-linked=\"Alcoa raised to Buy at Goldman\" data-tweet=\"$AA - Alcoa raised to Buy at Goldman https://seekingalpha.com/news/1430321-alcoa-raised-to-buy-at-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1430321-alcoa-raised-to-buy-at-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430291\" data-ts=\"1385382413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMS\" target=\"_blank\">FMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430291-fresenius-davita-shares-soar-following-scrapping-of-payment-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresenius, DaVita shares soar following scrapping of payment cut</a></h4><ul>   <li>Shares in Fresenius Medical Care (NYSE:<a href=\"https://seekingalpha.com/symbol/FMS\" title=\"Fresenius Medical Care AG &amp; Co. KGAA\">FMS</a>) are <font color=\"green\">+8.3%</font> and those of DaVita HealthCare Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a>) <font color=\"green\">+6.1%</font> after the Centers for Medicare &amp; Medicaid Services scrapped a proposed 9.4% cut in reimbursement rates for dialysis treatment for patients with end-stage renal disease.</li>    <li>Instead, payments for 2014 and 2015 they will remain flat.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1430291\" data-linked=\"Fresenius, DaVita shares soar following scrapping of payment cut\" data-tweet=\"$FMS $FMS $DVA - Fresenius, DaVita shares soar following scrapping of payment cut https://seekingalpha.com/news/1430291-fresenius-davita-shares-soar-following-scrapping-of-payment-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/1430291-fresenius-davita-shares-soar-following-scrapping-of-payment-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1430101\" data-ts=\"1385374949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1430101-world-stocks-rise-after-iran-nuclear-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World stocks rise after Iran nuclear deal</a></h4><ul>   <li>Global equities are <a href=\"http://www.bloomberg.com/news/2013-11-24/israel-stocks-rise-on-iran-deal-as-asian-futures-advance.html\" target=\"_blank\">mostly higher</a> following the <a href=\"https://seekingalpha.com/currents/search?query=iran\" target=\"_blank\">agreement</a> between Iran and the P5+1 great powers in which the Persian nation will limit its nuclear program in return for an easing of sanctions.</li>     <li>Airline stocks are having a particularly good day as crude oil <font color=\"red\">tumbles 1.5%</font>.</li>    <li>Gold is <font color=\"red\">-1.05%</font>, with its safe haven status apparently deemed less necessary - for now.</li>    <li>Japan <font color=\"green\">+1.5%</font>, Hong Kong <font color=\"red\">-0.05%</font>, China <font color=\"red\">-0.5%</font>, India <font color=\"green\">+1.9%</font>\n</li>    <li>EU Stoxx 50 <font color=\"green\">+0.4%</font>, London <font color=\"green\">+0.3%</font>, Paris <font color=\"green\">+0.4%</font>, Frankfurt <font color=\"green\">+0.8%</font>, Milan <font color=\"red\">-0.3%</font>, Madrid <font color=\"green\">+0.05%</font>.</li>     <li>U.S. stock futures: Dow <font color=\"green\">+0.3%</font>. S&amp;P <font color=\"green\">+0.3%</font>. Nasdaq <font color=\"green\">+0.3%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1430101\" data-linked=\"World stocks rise after Iran nuclear deal\" data-tweet=\"World stocks rise after Iran nuclear deal https://seekingalpha.com/news/1430101-world-stocks-rise-after-iran-nuclear-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1430101-world-stocks-rise-after-iran-nuclear-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":58,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}